Garen G. Bohlin, Director at Karyopharm Therapeutics Inc. (KPTI), bought 82,280 shares at $1.22 ($100K) on 2023-09-12, disclosed to the SEC on 2023-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 41,140 | $50K | 50.0% |
| 2 | $1.22 | 41,140 | $50K | 50.0% |
| Total | $1.22 avg | 82,280 | $100K | 100% |
| Filing → |
| KPTI | BUY | 2021-05-10 | $31K | — | Filing → |